Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells

Abstract

Wnt10b is a canonical Wnt ligand expressed in developing bone and has been linked to mesenchymal progenitor functions in mice and humans. Because Wnt signaling has been shown to play an important role in progenitor maintenance in a variety of adult tissues, we examined bone deposition and growth rates throughout postnatal development in Wnt10b-null mice. Using bone histomorphometry and micro–computed tomographic (µCT) studies, we demonstrate that trabecular bone deposition is slightly enhanced in Wnt10b-null mice at 1 month of age, followed by progressive loss with age. Importantly, we find that Wnt10b is required for maintenance of adult bone density in multiple backgrounds of inbred mice and that both copies of the Wnt10b gene are required to maintain normal bone density in 6-month-old animals. We go on to show that the loss in trabecular bone in Wnt10b-null mice is associated with a reduction in the number of bone marrow–derived mesenchymal progenitors (MPCs) using in vitro colony-forming unit assays and marker analysis. Analysis of osteogenic gene expression in primary bone marrow stromal cells demonstrated reductions in expression of several osteoblast differentiation markers. Taken together, our results indicate that Wnt10b is uniquely required for maintenance of mesenchymal progenitor activity in adult bone. The results show the significance of studying individual Wnt ligands and their potentially unique contribution in the context of aging and disease. © 2010 American Society for Bone and Mineral Research.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 45

1. 1.

   Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71-74.

   Not in our library10.1126/science.276.5309.71

2. 2.

   Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev. 2006;5:91-116.

   Not in our library10.1016/j.arr.2005.10.001

3. 3.

   Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005;8:739-750.

   Not in our library10.1016/j.devcel.2005.03.016

4. 4.

   Kronenberg HM. Developmental regulation of the growth plate. Nature. 2003;423:332-336.

   Not in our library10.1038/nature01657

5. 5.

   Noh T, Gabet Y, Cogan J, et al. Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. PLoS ONE. 2009;4:e5438.

   Not in our library10.1371/journal.pone.0005438

6. 6.

   Dao DY, Yang X, Flick LM, Chen D, Hilton MJ, O'Keefe RJ. Axin2 regulates chondrocyte maturation and axial skeletal development. J Orthop Res. 2010;28:89-95.

   Not in our library10.1002/jor.20954

7. 7.

   Bodine PVN, Zhao W, Kharode YP, et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol. 2004;18:1222-1237.

   Not in our library10.1210/me.2003-0498

8. 8.

   Lee N, Smolarz AJ, Olson S, et al. A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies. Br J Cancer. 2007;97:1552-1559.

   Not in our library10.1038/sj.bjc.6604069

9. 9.

   Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005;280:41342-41351.

   Not in our library10.1074/jbc.m502168200

10. 10.

    Boland GM, Perkins G, Hall DJ, Tuan RS. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem. 2004;93:1210-1230.

    Not in our library10.1002/jcb.20284

11. 11.

    De Boer J, Wang HJ, Van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng. 2004;10:393-401.

    Not in our library10.1089/107632704323061753

12. 12.

    Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005;8:727-738.

    Not in our library10.1016/j.devcel.2005.02.013

13. 13.

    Baksh D, Boland GM, Tuan RS. Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem. 2007;101:1109-1124.

    Not in our library10.1002/jcb.21097

14. 14.

    Liu G, Vijayakumar S, Grumolato L, et al. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol. 2009;185:67-75.

    Not in our library10.1083/jcb.200810137

15. 15.

    Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene. 2004;341:19-39.

    Not in our library10.1016/j.gene.2004.06.044

16. 16.

    Andrade AC, Nilsson O, Barnes KM, Baron J. Wnt gene expression in the post-natal growth plate: regulation with chondrocyte differentiation. Bone. 2007;40:1361-1369.

    Not in our library10.1016/j.bone.2007.01.005

17. 17.

    Zhou H, Mak W, Zheng Y, Dunstan CR, Seibel MJ. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem. 2008;283:1936-1945.

    Not in our library10.1074/jbc.m702687200

18. 18.

    Miranda-Carboni GA, Krum SA, Yee K, et al. A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors. Genes Dev. 2008;22:3077-3081.

    Not in our library10.1101/gad.1692808

19. 19.

    Bennett CN, Longo KA, Wright WS, et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. PNAS. 2005;102:3324-3329.

    Not in our library10.1073/pnas.0408742102

20. 20.

    Bennett CN, Ouyang H, Ma YL, et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res. 2007;22:1924-1932.

    Not in our library10.1359/jbmr.070810

21. 21.

    Tybulewicz VLJ, Crawford CE, Jackson PK, Bronson RT, Mulligan RC. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 1991;65:1153-1163.

    Not in our library10.1016/0092-8674(91)90011-m

22. 22.

    Lane TF, Lin C, Brown MA, Solomon E, Leder P. Gene replacement with the human BRCA1 locus: tissue specific expression and rescue of embryonic lethality in mice. Oncogene. 2000;19:4085-4090.

    Not in our library10.1038/sj.onc.1203760

23. 23.

    Glorieux FH, Travers R, Taylor A, et al. Normative data for iliac bone histomorphometry in growing children. Bone. 2000;26:103-109.

    Not in our library10.1016/s8756-3282(99)00257-4

24. 24.

    Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997;89:747-754.

    Not in our library10.1016/s0092-8674(00)80257-3

25. 25.

    Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755-764.

    Not in our library10.1016/s0092-8674(00)80258-5

26. 26.

    Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997;89:765-771.

    Not in our library10.1016/s0092-8674(00)80259-7

27. 27.

    Friedenstein AJ. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo. Haematol Blood Transfus. 1980;25:19-29.

    Not in our library10.1007/978-3-642-67319-1_3

28. 28.

    Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.

    Not in our library10.1038/nature00870

29. 29.

    Baddoo M, Hill K, Wilkinson R, et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem. 2003;89:1235-1249.

    Not in our library10.1002/jcb.10594

30. 30.

    Tropel P, Noel D, Platet N, Lgrand P, Benabid AL, Berger F. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res. 2004;295:395-406.

    Not in our library10.1016/j.yexcr.2003.12.030

31. 31.

    Hiroki H, Yu M, Yuji Y, et al. Flow cytometric discrimination of mesenchymal progenitor cells from bone marrow-adherent cell populations using CD34/44/45(−) and Sca-1(+) markers. J Orthop Sci. 2007;12:161-169.

    Not in our library10.1007/s00776-006-1098-6

32. 32.

    de Boer J, Siddappa R, Gaspar C, van Apeldoorn A, Fodde R, van Blitterswijk C. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone. 2004;34:818-826.

    Not in our library10.1016/j.bone.2004.01.016

33. 33.

    Qian Z, Chen L, Fernald AA, Williams BO, Le Beau MM. A critical role for Apc in hematopoietic stem and progenitor cell survival. J Exp Med. 2008;205:2163-2175.

    Not in our library10.1084/jem.20080578

34. 34.

    Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of β-catenin in mice. Genes Dev. 2008;22:2308-2341.

    Not in our library10.1101/gad.1686208

35. 35.

    Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002;157:303-314.

    Not in our library10.1083/jcb.200201089

36. 36.

    Willert J, Epping M, Pollack J, Brown P, Nusse R. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol. 2002;2:8.

    Not in our library10.1186/1471-213x-2-8

37. 37.

    Thal MA, Carvalho TL, He T, et al. Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage. PNAS. 2009;106:552-557.

    Not in our library10.1073/pnas.0802550106

38. 38.

    Park KW, Waki H, Villanueva CJ, et al. Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-{gamma} expression and adipocyte differentiation. Mol Endocrinol. 2008;22:2038-2048.

    Not in our library10.1210/me.2007-0454

39. 39.

    Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2:313-319.

    Not in our library10.1016/j.stem.2008.03.002

40. 40.

    Wright WS, Longo KA, Dolinsky VW, et al. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes. 2007;56:295-303.

    Not in our library10.2337/db06-1339

Cited by papers we hold 5

• Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease · 2024
  No notice
• Bone Aging, Cellular Senescence, and Osteoporosis · 2021
  No notice
• Senile Osteoporosis: The Involvement of Differentiation and Senescence of Bone Marrow Stromal Cells · 2020
  No notice
• WNT7B Promotes Bone Formation in part through mTORC1 · 2014
  No notice
• WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.